Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/51578
DC FieldValueLanguage
dc.contributor.authorMarin, R.en_US
dc.contributor.authorGuerra, B.en_US
dc.contributor.authorHernández-Jiménez, J. G.en_US
dc.contributor.authorKang, X. L.en_US
dc.contributor.authorFraser, J. D.en_US
dc.contributor.authorLópez, F. J.en_US
dc.contributor.authorAlonso, R.en_US
dc.contributor.otherGuerra, Borja-
dc.contributor.otherMarin Cruzado, Raquel-
dc.date.accessioned2018-11-25T01:52:34Z-
dc.date.available2018-11-25T01:52:34Z-
dc.date.issued2003en_US
dc.identifier.issn0306-4522en_US
dc.identifier.urihttp://hdl.handle.net/10553/51578-
dc.description.abstractThe pathology of Alzheimer's disease includes amyloid-β peptide aggregation that contributes to degeneration of cholinergic neurons. Even though the underlying molecular mechanisms remain unclear, recent in vitro evidence supports a protective role for estrogens against several neurotoxic agents. Here we report that, in a murine cholinergic cell line (SN56), the massive cell death induced by 1–40 fragment of amyloid-β peptide was prevented by 17β-estradiol through a mechanism that may involve estrogen receptor activation. The protective effect of estradiol was observed in a dose-dependent manner, and was completely blocked by the pure antiestrogen ICI 182,780. In contrast, the inactive isomer 17α-estradiol consistently showed weaker neuroprotection than the native hormone that was unaffected by ICI 182,780 treatment. In addition, equivalent concentrations of 17β-estradiol enhanced luciferase activity in cells transfected with a luciferase reporter gene driven by tandem estrogen response elements. Estrogen-induced luciferase activity was blocked by ICI 182,780, indicating estrogen receptor-dependent transcriptional activity. We also observed by reverse transcription–polymerase chain reaction, Western blot and immunocytochemistry that increasing concentrations of 17β-estradiol enhanced the expression of estrogen receptor α mRNA and protein during amyloid-β-induced toxicity. Under these conditions, it was found by confocal microscopy that the localization of estrogen receptor α in the absence of hormone was mainly extranuclear. However, the receptor was consistently observed also at the nuclear region after estrogen exposure. Overall, these data suggest that estrogen may exert neuroprotective effects against amyloid-β-induced toxicity by activation of estrogen receptor-mediated pathways. In addition, intracellular estrogen receptors are up-regulated by their cognate hormone even during exposure to neurotoxic agents.en_US
dc.languageengen_US
dc.publisher0306-4522-
dc.relation.ispartofNeuroscienceen_US
dc.sourceNeuroscience[ISSN 0306-4522],v. 121 (4), p. 917-926en_US
dc.subject.otherAmyloid-β peptideen_US
dc.subject.otherEstrogenen_US
dc.subject.otherICI 182,780en_US
dc.subject.otherNeuroprotectionen_US
dc.subject.otherSN56 cellsen_US
dc.subject.otherEstrogen receptoren_US
dc.titleEstradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptoren_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/S0306-4522(03)00464-0en_US
dc.identifier.scopus0142247461-
dc.identifier.isi000186469800012-
dcterms.isPartOfNeuroscience-
dcterms.sourceNeuroscience[ISSN 0306-4522],v. 121 (4), p. 917-926-
dc.contributor.authorscopusid7101784493-
dc.contributor.authorscopusid7006442271-
dc.contributor.authorscopusid6506116086-
dc.contributor.authorscopusid7102354339-
dc.contributor.authorscopusid55193665900-
dc.contributor.authorscopusid36730433200-
dc.contributor.authorscopusid20233404200-
dc.description.lastpage926en_US
dc.identifier.issue4-
dc.description.firstpage917en_US
dc.relation.volume121en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000186469800012-
dc.contributor.daisngid664469-
dc.contributor.daisngid909211-
dc.contributor.daisngid3085050-
dc.contributor.daisngid13656824-
dc.contributor.daisngid227653-
dc.contributor.daisngid36626-
dc.contributor.daisngid28128791-
dc.identifier.investigatorRIDG-9739-2015-
dc.identifier.investigatorRIDH-5790-2014-
dc.utils.revisionen_US
dc.identifier.ulpgcNoen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr3,601
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0003-4355-5682-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameGuerra Hernández, Carlos Borja-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

66
checked on Apr 21, 2024

WEB OF SCIENCETM
Citations

56
checked on Oct 2, 2022

Page view(s)

42
checked on May 20, 2023

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.